- Home
- SERV vs AGL Comparison
SERV vs AGL Comparison
Compare SERV & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERV
- AGL
- Stock Information
- Founded
- SERV 2017
- AGL 2016
- Country
- SERV United States
- AGL United States
- Employees
- SERV N/A
- AGL N/A
- Industry
- SERV Industrial Specialties
- AGL Managed Health Care
- Sector
- SERV Consumer Discretionary
- AGL Health Care
- Exchange
- SERV Nasdaq
- AGL Nasdaq
- Market Cap
- SERV 964.9M
- AGL 894.1M
- IPO Year
- SERV N/A
- AGL 2021
- Fundamental
- Price
- SERV $18.26
- AGL $3.10
- Analyst Decision
- SERV Strong Buy
- AGL Hold
- Analyst Count
- SERV 3
- AGL 18
- Target Price
- SERV $17.00
- AGL $4.03
- AVG Volume (30 Days)
- SERV 13.2M
- AGL 4.2M
- Earning Date
- SERV 02-15-2025
- AGL 02-25-2025
- Dividend Yield
- SERV N/A
- AGL N/A
- EPS Growth
- SERV N/A
- AGL N/A
- EPS
- SERV N/A
- AGL N/A
- Revenue
- SERV $1,679,360.00
- AGL $5,594,117,000.00
- Revenue This Year
- SERV $836.66
- AGL $41.65
- Revenue Next Year
- SERV $598.41
- AGL $9.98
- P/E Ratio
- SERV N/A
- AGL N/A
- Revenue Growth
- SERV 692.32
- AGL 54.10
- 52 Week Low
- SERV $1.77
- AGL $1.50
- 52 Week High
- SERV $30.00
- AGL $7.73
- Technical
- Relative Strength Index (RSI)
- SERV N/A
- AGL 74.35
- Support Level
- SERV N/A
- AGL $2.03
- Resistance Level
- SERV N/A
- AGL $3.05
- Average True Range (ATR)
- SERV 0.00
- AGL 0.24
- MACD
- SERV 0.00
- AGL 0.12
- Stochastic Oscillator
- SERV 0.00
- AGL 86.64
About SERV Serve Robotics Inc. Common Stock
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an advanced, AI-robotics mobility platform, with last-mile delivery in cities as its first application.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.